Clinical Trials
20 trialsNCT06728072 2026-05-06
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Virginia Commonwealth University
Phase 2 Recruiting
NCT06569368 2026-04-16
Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06627270 2026-03-05
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Case Comprehensive Cancer Center
Phase 2 Recruiting
NCT06356597 2026-02-24
Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial
Shanghai Jiao Tong University School of Medicine
Phase 2 Active not recruiting
NCT06616597 2026-02-19
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT04729322 2025-12-23
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05748145 2025-11-18
Metronidazole as Preoperative Therapy in CRC / FusoMetro-001
Oncology Institute of Southern Switzerland
Phase 2 Recruiting
NCT07144657 2025-08-27
GastricMALToma
National Taiwan University Hospital
Phase 2 Not yet recruiting
NCT06793137 2025-01-29
Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
AC Camargo Cancer Center
Phase 2 Recruiting
NCT05462496 2024-10-15
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Recruiting
NCT04312360 2023-09-07
MEFO
Zealand University Hospital
Phase 2 Completed
NCT02682485 2023-04-26
SES-DTA
University of Chicago
Phase 2 Withdrawn
NCT05774964 2023-03-20
Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases
Liaoning Cancer Hospital & Institute
Phase 2 Unknown
NCT05720559 2023-02-09
Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection
Liaoning Cancer Hospital & Institute
Phase 2 Not yet recruiting
NCT04273997 2021-09-22
Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds
S.L.A. Pharma AG
Phase 2 Unknown
NCT04264676 2020-11-25
Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer
Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT01279252 2019-01-25
CLEAR
King's College Hospital NHS Trust
Phase 2 Completed
NCT00002682 2018-10-24
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02388581 2016-03-25
First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL
National Health Research Institutes, Taiwan
Phase 2 Unknown
NCT00003151 2012-07-02
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed